Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study

OBJECTIVE: To determine the differences between recommendations by the National Comprehensive Cancer Network (NCNN) guidelines and Food and Drug Administration approvals of anticancer drugs, and the evidence cited by the NCCN to justify recommendations where differences exist. DESIGN: Retrospective...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ
Autori principali: Wagner, Jeffrey, Marquart, John, Ruby, Julia, Lammers, Austin, Mailankody, Sham, Kaestner, Victoria, Prasad, Vinay
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group Ltd. 2018
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838851/
https://ncbi.nlm.nih.gov/pubmed/29514787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.k668
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi